Fund
Merck Global Health Innovation Fund
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 4
- Lead
- 0
- New entries
- 3
- Follow ons
- 1
- Latest operation
- 24 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 24 Sept | United States, Biotech | Series C | 75 M$ | Existing investor |
| 01 Sept | United States | Series B | 32 M$ | Participant |
| 11 Aug | United States, Biotech | Series A | 75 M$ | Participant |
| 16 Mar | United States, Biotech | Series B | 45 M$ | Participant |
Co investors 31 funds crossed
- 8VC 1 operation
- Alexandria Venture Investments 1 operation
- Amgen Ventures 1 operation
- Andreessen Horowitz 1 operation
- Artis Ventures 1 operation
- Catalio Capital Management 1 operation
- Civilization Ventures 1 operation
- DFJ Growth 1 operation
- Discovery Ventures 1 operation
- Droia Ventures 1 operation
- Eli Lilly and Company 1 operation
- Everbright Biofund 1 operation
- First Spark Ventures 1 operation
- Forge Life Science Partners 1 operation
- Godfrey Capital 1 operation
- Goldcrest Capital 1 operation
- GRIDS Capital 1 operation
- Innovatus Capital Partners 1 operation
- Intermountain Ventures 1 operation
- Labcorp Venture Fund 1 operation
- LG Technology Ventures 1 operation
- Pear VC 1 operation
- Playground Global 1 operation
- Premji Invest 1 operation
- Quadrille Capital 1 operation
- RA Capital Management 1 operation
- Regeneron Ventures 1 operation
- S32 1 operation
- Sigmas Group 1 operation
- The Venture Collective 1 operation
- Wild Tree Ventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.